Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: Bio - Caught on Camera

Giorgos Mazonakis Was Taken to Hospital Without a Pulse After Athens Clinic Emergency and Died at 54

Greek singer Giorgos Mazonakis, aged 54, died after a cardiac arrest at an Athens clinic. Known for reshaping Greek pop music, his death has prompted widespread tributes.

International Business Times UK · Sep 9

UC Berkeley, UC Davis pause Course Credit CPT applications after ICE warning

UC Berkeley and UC Davis have paused Course Credit CPT applications for international students following new ICE guidance and increased federal scrutiny. Both universities will continue processing Degree-Requirement CPT, while reviewing whether other practical-training arrangements comply with immigration rules.

The Economic Times · Aug 27

What to Expect From Bio-Techne's Next Quarterly Earnings Report

Bio-Techne is scheduled to post its fourth-quarter results soon, and analysts project a single-digit earnings decline.

Barchart · Jul 20

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Bio-Techne Stock Underperforming the S&P 500?

While Bio-Techne stock has underperformed the broader market over the past year, analysts remain moderately bullish about its prospects.

Barchart · Jun 22

Are Wall Street Analysts Bullish on Bio-Techne Stock?

While Bio-Techne has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart · May 25

What to Expect From Bio-Techne's Q3 2026 Earnings Report

Bio-Techne is set to announce its third-quarter earnings next month, and Wall Street expects the company’s EPS to decrease by a single digit.

Barchart · Apr 17

How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks

Bio-Techne has underperformed other biotechnology stocks over the past year, yet analysts remain moderately optimistic about the stock’s growth potential.

Barchart · Mar 20

Read news from The Economist, FT, and more,
with one subscription

How to acquire active contagion sample in Bio-Research and analyze it in Marathon – Selection Pressures 4 Contract guide

The final sample to find.

Destructoid · Mar 12

How to synthesize SIMbiont in Quarantine in Marathon – Parasitism 5 guide

The final one.

Destructoid · Mar 8

How to download research clearance in Maintenance and extract Synthsilk Sample in Marathon – Parasitism 4 guide

Get the sample for research.

Destructoid · Mar 8

How to extract Biotic Sample from Sparkleaf in Bio-Research in Marathon – Parasitism 3 contract guide

Inject it!

Destructoid · Mar 8

Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector?

Despite Bio-Techne’s weak performance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Barchart · Dec 16, 2025

The best probiotics for women, recommended by health experts

‘Clinical trials have proven that supplements that contain live bacteria can help by reducing symptoms of bacterial vaginosis and thrush,’ says Dr Megan Rossi

The Independent UK · Aug 20, 2025

Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure

Avantor Inc. (NYSE:AVTR) stock is trading lower on Friday after the company reported worse-than-expected second-quarter 2025 adjusted EPS.

Benzinga · Aug 1, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Aug 1, 2025

Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings

Bio-Rad Laboratories, Inc. (NYSE:BIO) reported better-than-expected second-quarter financial results on Thursday.

International Business Times · Jul 1, 2025

The Future of Cancer Treatment Is Here — And It Starts with the Right Clinical Trial

Cancer research no longer moves slowly; it advances rapidly. Revolutionary discoveries in precision medicine, immunotherapy, and gene editing emerge almost weekly, yet many patients still confront enormous hurdles when they look for cutting‑edge options.

Barchart · May 19, 2025

Do Wall Street Analysts Like Bio-Techne Stock?

Bio-Techne has notably underperformed the broader market over the past year, and analysts remain cautiously optimistic about the stock’s prospects.

Barchart · Apr 1, 2025

Is Bio-Techne Corporation Stock Underperforming the S&P 500?

Despite Bio-Techne Corporation’s underperformance relative to the S&P 500 over the past year, analysts maintain a bullish outlook on the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US · Mar 30, 2025

Biotech group warns exit of top FDA vaccine official will ‘erode scientific standards’

Rare admonition from a sector that has largely been silent in the face of the second Trump administration

Barchart · Feb 18, 2025

Bio-Techne Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Bio-Techne's underperformance relative to the broader market over the past year, Wall Street analysts remain bullish on the stock's prospects.

Bored Panda · Jan 29, 2025

Cryonics Start-Up Extending Life For $200,000 Sparks Hilarious Reactions

"I swear I've seen this movie." The post Cryonics Start-Up Extending Life For $200,000 Sparks Hilarious Reactions first appeared on Bored Panda.

Barchart · Dec 29, 2024

Is This Penny Stock a Buy After a 180% Rally?

Bio-Path Holdings surged 180% on promising obesity drug results. Discover why this penny stock's pivot from cancer treatments and Nasdaq delisting challenges could matter for investors.

Barchart · Nov 21, 2024

Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb or Sink?

Bio-Techne has underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects.

The Independent UK · Oct 25, 2024

10 best probiotics for supporting your gut, according to experts

Support your gut health, boost your immune system and reduce bloating with these probiotic supplements

Barchart · Sep 30, 2024

Bio-Rad Laboratories Stock: Is BIO Underperforming the Healthcare Sector?

Despite Bio-Rad Laboratories’ underperformance relative to the healthcare sector over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

1 2

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

International Students

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.